TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Price : 56.05 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 51.10 | 56.87 | 49.97 | 54.27 | 5.558M |
| Aug 20, 2026 | 51.65 | 53.18 | 50.52 | 50.56 | 2.436M |
| Aug 19, 2026 | 51.62 | 52.34 | 50.71 | 51.69 | 1.290M |
| Aug 18, 2026 | 49.28 | 50.29 | 48.98 | 50.26 | 1.195M |
| Aug 17, 2026 | 48.74 | 49.80 | 48.50 | 49.28 | 1.063M |
| Aug 14, 2026 | 47.27 | 48.92 | 47.27 | 48.74 | 1.073M |
| Aug 13, 2026 | 49.70 | 49.70 | 47.53 | 47.94 | 2.770M |
| Aug 12, 2026 | 50.00 | 50.54 | 49.34 | 49.50 | 2.018M |
| Aug 11, 2026 | 49.29 | 50.35 | 49.00 | 49.90 | 1.501M |
| Aug 10, 2026 | 49.26 | 50.00 | 48.50 | 49.16 | 1.912M |
| Aug 07, 2026 | 49.96 | 50.19 | 49.11 | 49.76 | 1.768M |
| Aug 06, 2026 | 49.99 | 50.60 | 49.46 | 49.55 | 1.405M |
| Aug 05, 2026 | 48.22 | 50.03 | 48.22 | 49.88 | 2.841M |
| Aug 04, 2026 | 46.16 | 49.00 | 45.36 | 48.74 | 2.866M |
| Aug 03, 2026 | 51.06 | 52.65 | 45.82 | 46.17 | 6.422M |
| Jul 31, 2026 | 53.46 | 53.46 | 51.55 | 52.03 | 2.490M |
| Jul 30, 2026 | 53.48 | 54.34 | 52.71 | 53.53 | 2.852M |
| Jul 29, 2026 | 54.87 | 54.98 | 52.81 | 53.48 | 2.916M |
| Jul 28, 2026 | 56.00 | 56.28 | 54.61 | 54.87 | 2.326M |
| Jul 27, 2026 | 57.30 | 57.58 | 55.60 | 55.75 | 1.680M |
| Jul 24, 2026 | 56.01 | 56.45 | 53.86 | 56.04 | 1.436M |
| Jul 23, 2026 | 52.26 | 55.58 | 51.28 | 55.50 | 2.961M |
| Jul 22, 2026 | 53.52 | 53.83 | 52.60 | 52.68 | 1.335M |
| Jul 21, 2026 | 54.24 | 55.00 | 53.20 | 53.95 | 1.490M |
| Jul 20, 2026 | 55.75 | 56.25 | 53.94 | 53.96 | 1.029M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Krystal Biotech, Inc. | 341.78 |
| MAIA Biotechnology, Inc. | 1.355 |
| Vericel Corp. | 42.36 |
| Incyte Corp. | 127.99 |
| Regeneron Pharmaceuticals, Inc. | 828.72 |
Price Related Metrics
| PE Ratio | 20.41 |
| PS Ratio | 11.18 |
| PEG Ratio | 0.0322 |
| Price to Book Value | 14.20 |
| Price to Free Cash Flow | 514.00 |
| Earnings Yield | 4.90% |
| Market Cap | 8.580B |
| PEGY Ratio | 0.0322 |
| Operating PE Ratio | 65.55 |
| Normalized PE Ratio | 20.03 |